Clinical Trial Update: Oral Peanut Immunotherapy for Peanut Allergic Patients [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial of oral peanut immunotherapy for peanut allergy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Hypersensitivity

Drugs mentioned

• Peanut oral immunotherapy (peanut OIT)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Peanut Hypersensitivity | EARLY_Phase 1 | Status: COMPLETED